Loss of cyclin‐dependent kinase‐like 2 predicts poor prognosis in gastric cancer, and its overexpression suppresses cells growth and invasion

Cyclin‐dependent kinase‐like 2 (CDKL2), a new member of the cyclin‐dependent kinase family, may be involved in gastric cancer (GC) progression. Thus, we conducted this study to explore the clinical effect of CDKL2 in GC. Immunohistochemistry was used to measure CDKL2 levels in gastric tissues. The a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Fang, Chia‐Lang, Uen, Yih‐Huei, Chen, Han‐Kun, Hseu, You‐Cheng, Lin, Chih‐Chan, Hung, Shih‐Ting, Sun, Ding‐Ping, Lin, Kai‐Yuan
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6051174/
https://ncbi.nlm.nih.gov/pubmed/29790675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1577
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados